Growth Metrics

RAPT Therapeutics (RAPT) Other Accumulated Expenses: 2020-2023

Historic Other Accumulated Expenses for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $178,000.

  • Therapeutics' Other Accumulated Expenses rose 7.69% to $168,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $168,000, marking a year-over-year increase of 7.69%. This contributed to the annual value of $178,000 for FY2023, which is 25.21% down from last year.
  • Therapeutics' Other Accumulated Expenses amounted to $178,000 in FY2023, which was down 25.21% from $238,000 recorded in FY2022.
  • Therapeutics' Other Accumulated Expenses' 5-year high stood at $328,000 during FY2020, with a 5-year trough of $178,000 in FY2023.
  • Over the past 3 years, Therapeutics' median Other Accumulated Expenses value was $238,000 (recorded in 2022), while the average stood at $223,333.
  • Data for Therapeutics' Other Accumulated Expenses shows a maximum YoY dropped of 25.21% (in 2023) over the last 5 years.
  • Over the past 4 years, Therapeutics' Other Accumulated Expenses (Yearly) stood at $328,000 in 2020, then fell by 22.56% to $254,000 in 2021, then fell by 6.30% to $238,000 in 2022, then decreased by 25.21% to $178,000 in 2023.